PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.90%
Revenue growth above 1.5x JHX's 7.97%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-67.09%
Negative gross profit growth while JHX is at 49.26%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.13%
Negative EBIT growth while JHX is at 413.89%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.13%
Negative operating income growth while JHX is at 413.89%. Joel Greenblatt would press for urgent turnaround measures.
13.90%
Net income growth under 50% of JHX's 1255.56%. Michael Burry would suspect the firm is falling well behind a key competitor.
8.33%
EPS growth under 50% of JHX's 1009.09%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
8.33%
Diluted EPS growth under 50% of JHX's 1009.09%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.01%
Share reduction while JHX is at 4.76%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.05%
Reduced diluted shares while JHX is at 4.83%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
187.25%
10Y CAGR of 187.25% while JHX is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
60.19%
5Y CAGR of 60.19% while JHX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
16.73%
3Y CAGR of 16.73% while JHX is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
165.62%
10Y net income/share CAGR of 165.62% while JHX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
32.81%
Net income/share CAGR of 32.81% while JHX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-36.76%
Negative 3Y CAGR while JHX is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.54%
Equity/share CAGR of 63.54% while JHX is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.